Alisma orientalis Beverage Treats Atherosclerosis by Regulating Gut Microbiota in ApoE-/- Mice
BackgroundAlisma orientalis beverage (AOB) is a Chinese traditional medicine formulated with a diversity of medicinal plants and used for treating metabolic syndrome and atherosclerosis (AS) since time ago. Given the current limited biological research on AOB, the mechanism by which AOB treats AS is...
Saved in:
Main Authors: | Boran Zhu (Author), Yi Zhai (Author), Mengjiao Ji (Author), Yanan Wei (Author), Jiafei Wu (Author), Wenda Xue (Author), Wei wei Tao (Author), Haoxin Wu (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PI3K/AKT/SERBP-1 pathway regulates Alisma orientalis beverage treatment of atherosclerosis in APOE−/− high-fat diet mice
by: Ruiyi Liu, et al.
Published: (2023) -
Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice
by: Min Wu, et al.
Published: (2020) -
The Role of Gut Microbiota in Atherosclerosis and Hypertension
by: Junli Ma, et al.
Published: (2018) -
Fecal microbiota transplantation validates the importance of gut microbiota in an ApoE−/− mouse model of chronic apical periodontitis-induced atherosclerosis
by: Guowu Gan, et al.
Published: (2024) -
Effects of salidroside on atherosclerosis: potential contribution of gut microbiota
by: Si-Fan Fei, et al.
Published: (2024)